King AA - Search Results

1

Parent education and biologic factors influence on cognition in sickle cell anemia.

King AA, Strouse JJ, Rodeghier MJ, Compas BE, Casella JF, McKinstry RC, Noetzel MJ, Quinn CT, Ichord R, Dowling MM, Miller JP, Debaun MR. King AA, et al. Am J Hematol. 2014 Feb;89(2):162-7. doi: 10.1002/ajh.23604. Am J Hematol. 2014. PMID: 24123128 Free PMC article.

2

Hypoglycemia in Beckwith-Wiedemann syndrome.

DeBaun MR, King AA, White N. DeBaun MR, et al. Among authors: king aa. Semin Perinatol. 2000 Apr;24(2):164-71. doi: 10.1053/sp.2000.6366. Semin Perinatol. 2000. PMID: 10805171 Review.

3

Malignant peripheral nerve sheath tumors in neurofibromatosis 1.

King AA, Debaun MR, Riccardi VM, Gutmann DH. King AA, et al. Am J Med Genet. 2000 Aug 28;93(5):388-92. Am J Med Genet. 2000. PMID: 10951462

4

Inadequate recognition of education resources required for high-risk students with sickle cell disease.

Herron S, Bacak SJ, King A, DeBaun MR. Herron S, et al. Arch Pediatr Adolesc Med. 2003 Jan;157(1):104. doi: 10.1001/archpedi.157.1.104. Arch Pediatr Adolesc Med. 2003. PMID: 12517203 No abstract available.

5

An education program to increase teacher knowledge about sickle cell disease.

King AA, Tang S, Ferguson KL, DeBaun MR. King AA, et al. J Sch Health. 2005 Jan;75(1):11-4. doi: 10.1111/j.1746-1561.2005.tb00003.x. J Sch Health. 2005. PMID: 15776876

6

A multidisciplinary health care team's efforts to improve educational attainment in children with sickle-cell anemia and cerebral infarcts.

King A, Herron S, McKinstry R, Bacak S, Armstrong M, White D, DeBaun M. King A, et al. J Sch Health. 2006 Jan;76(1):33-7. doi: 10.1111/j.1746-1561.2006.00064.x. J Sch Health. 2006. PMID: 16457683

7

A pilot randomized education rehabilitation trial is feasible in sickle cell and strokes.

King AA, White DA, McKinstry RC, Noetzel M, Debaun MR. King AA, et al. Neurology. 2007 Jun 5;68(23):2008-11. doi: 10.1212/01.wnl.0000264421.24415.16. Neurology. 2007. PMID: 17548550 Clinical Trial.

8

Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts.

King AA, Noetzel M, White DA, McKinstry RC, Debaun MR. King AA, et al. Pediatr Blood Cancer. 2008 Mar;50(3):599-602. doi: 10.1002/pbc.21338. Pediatr Blood Cancer. 2008. PMID: 17985350 Clinical Trial.

9

Need for cognitive rehabilitation for children with sickle cell disease and strokes.

King AA, DeBaun MR, White DA. King AA, et al. Expert Rev Neurother. 2008 Feb;8(2):291-6. doi: 10.1586/14737175.8.2.291. Expert Rev Neurother. 2008. PMID: 18271713 Review.

10

Design of the silent cerebral infarct transfusion (SIT) trial.

Casella JF, King AA, Barton B, White DA, Noetzel MJ, Ichord RN, Terrill C, Hirtz D, McKinstry RC, Strouse JJ, Howard TH, Coates TD, Minniti CP, Campbell AD, Vendt BA, Lehmann H, Debaun MR. Casella JF, et al. Among authors: king aa. Pediatr Hematol Oncol. 2010 Mar;27(2):69-89. doi: 10.3109/08880010903360367. Pediatr Hematol Oncol. 2010. PMID: 20201689 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters